Literature DB >> 1566352

Cell subsets responding to purified hepatocytes and evidence of indirect recognition of hepatocyte major histocompatibility complex class I antigen. II. In vitro-generated "memory" cells to class I+ class II- hepatocytes.

G L Bumgardner1, S Chen, P S Almond, F H Bach, N L Ascher, A J Matas.   

Abstract

Purified hepatocytes stimulate the development of L3T4-, Ly2+ allospecific cytolytic T cells from naive splenocytes after 5 days in primary mixed lymphocyte-hepatocyte culture (MLHC). Previous studies indicate that the immunogenicity of purified hepatocytes relates to the expression of MHC class I antigen. The purpose of the following experiments was to identify the cell subsets that specifically recognize hepatocyte MHC class I antigen. We employed primed lymphocyte testing (PLT) in order to test for a "second set" response. Cells from primary MLHC reverted to a functionally quiescent state when they were grown in culture for an additional 7-9 days. The cells were then tested for cytotoxicity or rechallenged with allogeneic, syngeneic, or "third party" hepatocytes and tested for proliferation. Allocytotoxicity was low on day 12 in MLHC, but the sensitized cell population demonstrated peak proliferation in response to allogeneic hepatocytes 48 hr after restimulation. When bulk PLT cells were immunodepleted, both L3T4+, Ly2- and L3T4-, Ly2+ T cell subsets demonstrated a "second set" response to allogeneic hepatocytes consistent with specific recognition of and retention of "memory" for hepatocyte MHC class I alloantigen.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1566352     DOI: 10.1097/00007890-199204000-00029

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  1 in total

1.  Correction of factor IX deficiency in mice by embryonic stem cells differentiated in vitro.

Authors:  Jeffrey H Fair; Bruce A Cairns; Michael A Lapaglia; Montserrat Caballero; W Andrew Pleasant; Seigo Hatada; Hyung-Suk Kim; Tong Gui; Larysa Pevny; Anthony A Meyer; Darrel W Stafford; Oliver Smithies; Jeffrey A Frelinger
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.